| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327414 | Gynecologic Oncology | 2005 | 6 Pages |
Abstract
Adjuvant therapy for UPSC and CCC with intraperitoneal 32P and vaginal brachytherapy after comprehensive surgical staging is feasible, well tolerated, and warrants further study on a larger scale.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Achilles J. Fakiris, David H. Moore, Shailaja R. Reddy, Katherine Y. Look, Constantin T. Yiannoutsos, Marcus E. Randall, Higinia R. Cardenes,